Tradestie Institutional Equity Comparison Engine

BLFS vs FEMY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BLFS Overall Edge

BLFS Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioLife Solutions Inc. (BLFS) driven by superior Valuation, Growth & Margin, Options & Structure while FEMY counters with relative strength in Momentum & Technical. Fundamentally, BLFS trades at 117.0x Forward P/E with 6.0% operating margin (+21.5% YoY revenue) versus FEMY at N/M Forward P/E and -763.9% operating margin (-18.9% YoY). In options structure, BLFS sits in BREAKOUT (6th %ile IV; Dealer Gamma Walls on Pro) against FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BLFS
BLFS 117.0x vs FEMY N/M Fwd P/E
Growth & Margin Winner BLFS
Op Margin 6.0% vs -763.9% ยท YoY +21.5% vs -18.9%
Momentum & Technical Winner FEMY
1Y +49.0% vs +54.8% ยท 52W Pos 95% vs 17%
Options & Structure Winner BLFS
BREAKOUT (6th %ile IV) vs UNCLASSIFIED (N/A IV)
BLFS NASDAQ
BioLife Solutions Inc.
Electromedical & Electrotherapeutic Apparatus
$38.61
+3.51% 1D
Market Cap $1.8B
1M Return +8.67%
1Y Return +49.02%
Forward P/E 117.0x
Unified AI Score
46.0 / 100 HOLD
Tech 27.0 Fund 46.0 Flow 59.0 Mom 56.0
FEMY NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap $11.9M
1M Return -22.42%
1Y Return +54.78%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 61.0 Fund 62.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BLFS +49.02% FEMY +54.78% Spread: +90.68 pp (FEMY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BLFS Revenue FEMY Revenue BLFS Op. Margin FEMY Op. Margin Margin Edge
FY2018 $20M N/A 18.5% N/A BLFS
FY2019 $30M N/A -0.8% N/A BLFS
FY2020 $50M $0M -13.0% -668.0% BLFS
FY2021 $120M $0M -29.5% -706.7% BLFS
FY2022 $80M $0M -7.8% -961.7% BLFS
FY2023 $70M $0M -25.3% -1353.4% BLFS
FY2024 $70M $0M -6.0% -1091.8% BLFS
FY2025 $100M $0M -17.3% -767.0% BLFS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BLFS (9) vs FEMY (1)
Institutional Metric BLFS FEMY Criterion Row Winner
Market Capitalization Scale $1.8B $11.9M Larger Scale BLFS
Trailing P/E Ratio Valuation 37.3x N/M Lower Multiple BLFS
Forward P/E Ratio Valuation 117.0x N/M Lower Multiple BLFS
Revenue Growth (YoY) Growth +21.5% -18.9% Higher Growth BLFS
Operating Margin (TTM) Profitability 6.0% -763.9% Higher Margin BLFS
Net Profit Margin Profitability 54.4% 0.0% Higher Margin BLFS
Return on Equity (ROE) Capital Efficiency 12.8% -425.0% Higher ROE BLFS
52-Week Range Position Momentum 95% ($18โ€“$40) 17% ($0โ€“$6) Stronger Trend BLFS
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 31% Vol 4.01ฮฒ ยท 72% Vol Lower Realized Risk BLFS
Unified Institutional Score Composite Signal 46.0 / 100 (HOLD) 52.6 / 100 (HOLD) Higher Composite FEMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BLFS vs FEMY Buy Guide
BLFS BREAKOUT
38d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live BLFS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FEMY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BLFS nor FEMY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.